Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
A laboratory test identified by CPT® Code 80357 is utilized to measure the levels of ketamine and its metabolite, norketamine, in serum or plasma samples. Ketamine is classified as an N-methyl-D-aspartate receptor (NMDAR) antagonist, which means it works by blocking certain receptors in the brain that are involved in pain perception and mood regulation. This medication can be administered through various routes, including injection, ingestion, or inhalation, making it versatile in clinical settings. Ketamine is recognized for its potent analgesic (pain-relieving), sedative (calming), and amnesic (memory-impairing) properties, which contribute to its use in anesthesia, pain management, and the treatment of bronchospasm. One of the significant advantages of ketamine is its ability to maintain stable cardiovascular function while preserving airway reflexes, which enhances its safety profile as an anesthetic option for a diverse patient population. However, due to its dissociative effects, ketamine has also gained popularity among individuals seeking recreational use, leading to concerns regarding potential abuse. The testing process involves obtaining a blood sample through a separately reportable venipuncture, followed by analysis of the serum or plasma using quantitative gas chromatography-mass spectrometry, a highly sensitive and specific method for detecting and quantifying substances in biological samples.
© Copyright 2026 Coding Ahead. All rights reserved.
The laboratory test for ketamine and norketamine is indicated for various clinical scenarios where monitoring the levels of these substances is necessary. The following conditions may warrant this testing:
The procedure for testing ketamine and norketamine involves several critical steps to ensure accurate results. The first step is the collection of a blood sample, which is obtained through a venipuncture. This process involves inserting a needle into a vein, typically in the arm, to draw blood into a collection tube. It is essential that this venipuncture is performed in a sterile environment to prevent contamination and ensure the integrity of the sample. Once the blood sample is collected, it is processed to separate the serum or plasma from the cellular components. This separation is crucial as it allows for the analysis of the liquid portion of the blood, where ketamine and norketamine are present. Following this, the serum or plasma is subjected to quantitative gas chromatography-mass spectrometry (GC-MS). This sophisticated analytical technique enables the precise measurement of ketamine and norketamine levels in the sample, providing valuable information regarding the patient's exposure to these substances. The results obtained from this testing can guide clinical decisions related to anesthesia, pain management, and potential substance abuse interventions.
After the procedure, there are no specific post-procedure care requirements related to the blood draw itself, as venipuncture is a routine procedure with minimal risk. However, patients may be advised to apply pressure to the site of the blood draw to minimize bruising and bleeding. It is also important for healthcare providers to monitor the results of the ketamine and norketamine testing, as these results can influence ongoing treatment plans. If the levels of ketamine or norketamine are found to be outside the expected therapeutic range, further evaluation and adjustments to the patient's treatment regimen may be necessary. Additionally, if the testing is conducted due to concerns about substance abuse, appropriate follow-up and counseling may be recommended based on the findings.
| Short Descr | KETAMINE AND NORKETAMINE | Medium Descr | DRUG SCREENING KETAMINE AND NORKETAMINE | Long Descr | Ketamine and norketamine | Status Code | Not Valid for Medicare Purposes | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Code Not Recognized by OPPS when submitted on Outpatient Hospital Part B Bill Type (12x/13x) | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | T2D - Other tests - other | MUE | 1 |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2015-01-01 | Added | Added |
Get instant expert-level medical coding assistance.